We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMP
151
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$3.6M 0.07%
38,542
-350
-0.9% -$31.1K
SIG icon
152
Signet Jewelers
SIG
$3.55B
$3.57M 0.07%
31,349
-847
-3% -$93.7K
EEM icon
153
iShares MSCI Emerging Markets ETF
EEM
$28B
$3.57M 0.07%
85,815
-6,408
-7% -$283K
EMC
154
DELISTED
EMC CORPORATION
EMC
$3.48M 0.07%
118,850
-6,499
-5% -$188K
LUX
155
DELISTED
Luxottica Group
LUX
$3.45M 0.07%
66,242
-1,883
-3% -$101K
LOPE icon
156
Grand Canyon Education
LOPE
$3.71B
$3.41M 0.06%
83,678
-26,849
-24% -$1.17M
EFA icon
157
iShares MSCI EAFE ETF
EFA
$76.4B
$3.39M 0.06%
52,890
-7,204
-12% -$481K
MEOH icon
158
Methanex
MEOH
$4.32B
$3.37M 0.06%
50,421
+412
+0.8% +$27.3K
WFC icon
159
Wells Fargo
WFC
$261B
$3.32M 0.06%
63,982
+2,826
+5% +$145K
CAT icon
160
Caterpillar
CAT
$409B
$3.29M 0.06%
33,262
+1,017
+3% +$108K
TRIB
161
Trinity Biotech
TRIB
$5.7M
$3.26M 0.06%
1,190
-9
-0.8% -$29.2K
MANH icon
162
Manhattan Associates
MANH
$8.97B
$3.24M 0.06%
96,951
-876,280
-90% -$27.4M
AER icon
163
AerCap
AER
$23.9B
$3.24M 0.06%
+79,160
New +$3.6M
MO icon
164
Altria Group
MO
$122B
$3.14M 0.06%
68,364
+3,387
+5% +$145K
NVS icon
165
Novartis
NVS
$295B
$3.07M 0.06%
36,449
-1,624
-4% -$131K
MMM icon
166
3M
MMM
$89B
$3M 0.06%
25,287
+1,289
+5% +$155K
VZ icon
167
Verizon
VZ
$194B
$2.98M 0.06%
59,512
+17
+0% +$845
BAX icon
168
Baxter International
BAX
$11.6B
$2.95M 0.06%
75,724
-475
-0.6% -$19.3K
LGCYO
169
DELISTED
Legacy Reserves LP 8% Series B Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred
LGCYO
$2.93M 0.06%
118,900
-1,900
-2% -$47.2K
EVTC icon
170
Evertec
EVTC
$1.83B
$2.88M 0.05%
129,015
-2,578
-2% -$58.9K
BDX icon
171
Becton Dickinson
BDX
$43.1B
$2.88M 0.05%
25,921
-59
-0.2% -$6.73K
MKTX icon
172
MarketAxess Holdings
MKTX
$4.15B
$2.78M 0.05%
45,001
-390,331
-90% -$22M
ORCL icon
173
Oracle
ORCL
$331B
$2.75M 0.05%
71,795
+1,202
+2% +$48.7K
HON icon
174
Honeywell
HON
$77.1B
$2.69M 0.05%
32,115
+31
+0.1% +$2.63K
GIS icon
175
General Mills
GIS
$19.2B
$2.56M 0.05%
50,703
-1,778
-3% -$93.2K

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.